Back to all papers

Incremental value of a CCTA-derived AI-based ischemia algorithm over standard CCTA interpretation of predicting myocardial ischemia in patients with suspected coronary artery disease.

Authors

Nabeta T,Bär S,Maaniitty T,Kärpijoki H,Bax JJ,Saraste A,Knuuti J

Affiliations (7)

  • Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands.
  • Turku PET Centre, Turku University Hospital and University of Turku, Finland; Department of Cardiology, Bern University Hospital Inselspital, Bern, Switzerland.
  • Turku PET Centre, Turku University Hospital and University of Turku, Finland; Department of Clinical Physiology, Nuclear Medicine and PET, Turku University Hospital, Turku, Finland.
  • Turku PET Centre, Turku University Hospital and University of Turku, Finland.
  • Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands; Heart Center, Turku University Hospital and University of Turku, Turku, Finland; Faculty of Medicine, University of Turku, Turku, Finland.
  • Turku PET Centre, Turku University Hospital and University of Turku, Finland; Heart Center, Turku University Hospital and University of Turku, Turku, Finland; Faculty of Medicine, University of Turku, Turku, Finland.
  • Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands; Turku PET Centre, Turku University Hospital and University of Turku, Finland; Department of Clinical Physiology, Nuclear Medicine and PET, Turku University Hospital, Turku, Finland; Faculty of Medicine, University of Turku, Turku, Finland. Electronic address: [email protected].

Abstract

A novel artificial intelligence-guided quantitative computed tomography ischemia algorithm (AI-QCT<sub>ischemia</sub>) comprises a machine-learned method using atherosclerosis and vascular morphology features from coronary computed tomography angiography (CCTA) images to predict myocardial ischemia. This study evaluates the diagnostic performance of AI-QCT<sub>ischemia</sub> compared to standard CCTA interpretation in detecting myocardial ischemia. Patients with suspected coronary artery disease (CAD) undergoing CCTA were analyzed, with ischemia detected by stress [<sup>15</sup>O]H<sub>2</sub>O positron emission tomography (PET) as the reference. AI-QCT<sub>ischemia</sub> analysis was successfully completed in 84 ​% of patients undergoing CCTA. A total of 1746 patients (mean age 62 ​± ​10 years, 44 ​% male) were included. In visual CCTA reading, 518 (30 ​%) patients had obstructive CAD, defined as diameter stenosis of ≥50 ​%. Myocardial ischemia on PET was detected in 325 (19 ​%) patients whereas AI-QCT<sub>ischemia</sub> was positive in 430 (25 ​%) patients. The diagnostic accuracy, sensitivity, specificity, positive predictive value, and negative predictive value of the AI-QCT<sub>ischemia</sub> for the assessment of myocardial ischemia were 87 ​%, 81 ​%, 88 ​%, 61 ​%, and 95 ​%, respectively, compared to 86 ​%, 93 ​%, 85 ​%, 58 ​%, and 98 ​% for visual CCTA reading. AI-QCT<sub>ischemia</sub> demonstrated higher diagnostic accuracy, specificity, and positive predictive value, but lower sensitivity and negative predictive value than visual CCTA reading (p-value <0.001). Combining AI-QCT<sub>ischemia</sub> with visual CCTA reading improved ischemia discrimination compared with visual CCTA reading alone (area under the receiver operating characteristic curve 0.899 vs. 0.868, p ​< ​0.001). Among patients with suspected CAD, the AI-guided CCTA-derived ischemia algorithm demonstrated improved specificity as compared with visual CCTA reading but this was at a cost of decreased sensitivity, resulting in a slight improvement in diagnostic accuracy for predicting PET-defined myocardial ischemia. These findings suggest that AI-QCT<sub>ischemia</sub> may support clinicians in refining diagnostic decision-making and streamlining patient selection for further testing.

Topics

Journal Article

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.